• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型和 2 型糖尿病管理方法的综述:从生活方式改变到当前和新型靶点及治疗药物。

A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents.

机构信息

Department of Pharmacy, College of Medicine and Health Science, Debre Markos University, Debre Markos, Ethiopia.

Department of Medical Laboratory Science, College of Medicine and Health Science, Debre Markos University, Debre Markos, Ethiopia.

出版信息

Front Endocrinol (Lausanne). 2024 Oct 18;15:1440456. doi: 10.3389/fendo.2024.1440456. eCollection 2024.

DOI:10.3389/fendo.2024.1440456
PMID:39493778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11527681/
Abstract

Diabetes mellitus (DM) has emerged as an international health epidemic due to its rapid rise in prevalence. Consequently, scientists and or researchers will continue to find novel, safe, effective, and affordable anti-diabetic medications. The goal of this review is to provide a thorough overview of the role that lifestyle changes play in managing diabetes, as well as the standard medications that are currently being used to treat the condition and the most recent advancements in the development of novel medical treatments that may be used as future interventions for the disease. A literature search was conducted using research databases such as PubMed, Web of Science, Scopus, ScienceDirect, Wiley Online Library, Google Scholar, etc. Data were then abstracted from these publications using words or Phrases like "pathophysiology of diabetes", "Signe and symptoms of diabetes", "types of diabetes", "major risk factors and complication of diabetes", "diagnosis of diabetes", "lifestyle modification for diabetes", "current antidiabetic agents", and "novel drugs and targets for diabetes management" that were published in English and had a strong scientific foundation. Special emphasis was given to the importance of lifestyle modification, as well as current, novel, and emerging/promising drugs and targets helpful for the management of both T1DM and T2DM.

摘要

糖尿病(DM)因其患病率的迅速上升而成为一种国际健康流行病。因此,科学家和研究人员将继续寻找新颖、安全、有效且经济实惠的抗糖尿病药物。本综述的目的是全面概述生活方式改变在糖尿病管理中的作用,以及目前用于治疗该疾病的标准药物,以及开发新型治疗方法的最新进展,这些方法可能作为未来治疗该疾病的干预措施。使用 PubMed、Web of Science、Scopus、ScienceDirect、Wiley Online Library、Google Scholar 等研究数据库进行了文献检索。然后使用“糖尿病的病理生理学”、“糖尿病的症状和体征”、“糖尿病的类型”、“糖尿病的主要危险因素和并发症”、“糖尿病的诊断”、“糖尿病的生活方式改变”、“目前的抗糖尿病药物”和“糖尿病管理的新药物和靶点”等词或短语从这些出版物中提取数据,这些数据均以英语发表且具有坚实的科学基础。特别强调了生活方式改变的重要性,以及有助于 1 型和 2 型糖尿病管理的当前、新颖和新兴/有希望的药物和靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/543f2ef1c612/fendo-15-1440456-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/2048a3bbd663/fendo-15-1440456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/737ea80acf3a/fendo-15-1440456-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/44e468f56e99/fendo-15-1440456-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/fba33a1b7d84/fendo-15-1440456-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/8b207b0aa12b/fendo-15-1440456-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/bc85b29c1a3b/fendo-15-1440456-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/543f2ef1c612/fendo-15-1440456-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/2048a3bbd663/fendo-15-1440456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/737ea80acf3a/fendo-15-1440456-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/44e468f56e99/fendo-15-1440456-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/fba33a1b7d84/fendo-15-1440456-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/8b207b0aa12b/fendo-15-1440456-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/bc85b29c1a3b/fendo-15-1440456-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4464/11527681/543f2ef1c612/fendo-15-1440456-g007.jpg

相似文献

1
A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents.1 型和 2 型糖尿病管理方法的综述:从生活方式改变到当前和新型靶点及治疗药物。
Front Endocrinol (Lausanne). 2024 Oct 18;15:1440456. doi: 10.3389/fendo.2024.1440456. eCollection 2024.
2
Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches.评价 2 型糖尿病管理的降糖治疗和营养补充:分子方法的见解。
Biotechnol Lett. 2022 Feb;44(2):203-238. doi: 10.1007/s10529-022-03232-3. Epub 2022 Feb 4.
3
Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019.1 型和 2 型糖尿病胰岛素的事实说明书及 2002 年至 2019 年使用胰岛素的 2 型糖尿病患者抗糖尿病药物使用趋势
Diabetes Metab J. 2023 Mar;47(2):211-219. doi: 10.4093/dmj.2022.0346. Epub 2023 Feb 7.
4
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.贝母碱治疗 2 型糖尿病、高脂血症和高血压的疗效和安全性的荟萃分析。
J Ethnopharmacol. 2015 Feb 23;161:69-81. doi: 10.1016/j.jep.2014.09.049. Epub 2014 Dec 10.
5
Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review.远程医疗干预对 1 型和 2 型糖尿病管理的临床改善:系统荟萃评价。
J Med Internet Res. 2021 Feb 19;23(2):e23244. doi: 10.2196/23244.
6
Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.心理干预对改善 1 型和 2 型糖尿病自我管理的效果:系统综述。
Health Technol Assess. 2020 Jun;24(28):1-232. doi: 10.3310/hta24280.
7
Whether or Not the Effects of Supplementation Are Associated with Physical Exercises in T1DM and T2DM: A Systematic Review.补充剂的效果是否与 T1DM 和 T2DM 中的体育锻炼有关:系统评价。
Nutrients. 2020 Dec 31;13(1):124. doi: 10.3390/nu13010124.
8
Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.基于数据驱动的血糖动力学建模与预测:机器学习在 1 型糖尿病中的应用。
Artif Intell Med. 2019 Jul;98:109-134. doi: 10.1016/j.artmed.2019.07.007. Epub 2019 Jul 26.
9
An Insight into the Combat Strategies for the Treatment of Type 2 Diabetes Mellitus.洞悉 2 型糖尿病治疗的策略。
Mini Rev Med Chem. 2024;24(4):403-430. doi: 10.2174/1389557523666230517113936.
10
A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus.德谷胰岛素与甘精胰岛素300 U/mL治疗糖尿病的临床疗效与安全性综述
Clin Ther. 2017 Aug;39(8S2):S12-S33. doi: 10.1016/j.clinthera.2017.01.007. Epub 2017 Feb 7.

引用本文的文献

1
The Influence of a Christian, Seventh-Day Adventist Lifestyle Based on Religious Principles on the Risk of Developing Type 2 Diabetes Mellitus.基于宗教原则的基督教复临安息日会生活方式对2型糖尿病发病风险的影响
Healthcare (Basel). 2025 Aug 19;13(16):2044. doi: 10.3390/healthcare13162044.
2
Application of the C-reactive protein-triglyceride glucose index in predicting the risk of new-onset diabetes in the general population aged 45 years and older: a national prospective cohort study.C反应蛋白-甘油三酯血糖指数在预测45岁及以上普通人群新发糖尿病风险中的应用:一项全国性前瞻性队列研究。
BMC Endocr Disord. 2025 May 9;25(1):126. doi: 10.1186/s12902-025-01947-8.

本文引用的文献

1
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis.胰高血糖素样肽-1受体激动剂对2型糖尿病血糖控制、体重和血脂水平的比较疗效:系统评价和网状Meta分析
BMJ. 2024 Jan 29;384:e076410. doi: 10.1136/bmj-2023-076410.
2
Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration.1 型糖尿病干细胞治疗的现状:批判与前瞻性思考。
Stem Cell Res Ther. 2024 Jan 29;15(1):23. doi: 10.1186/s13287-024-03636-0.
3
Novel Therapeutic Agents for Management of Diabetes Mellitus: A Hope for Drug Designing against Diabetes Mellitus.
用于糖尿病管理的新型治疗药物:糖尿病药物设计的希望
Life (Basel). 2024 Jan 8;14(1):99. doi: 10.3390/life14010099.
4
Validation of Blood Glucose and Lipid-Lowering Effect of Solvent Fractions of the Shoot Tips in Streptozotocin-Induced Diabetic Mice.链脲佐菌素诱导的糖尿病小鼠茎尖溶剂提取物降血糖和降血脂作用的验证
Glob Adv Integr Med Health. 2024 Jan 13;13:27536130231225464. doi: 10.1177/27536130231225464. eCollection 2024 Jan-Dec.
5
Dopamine 2 agonists for the management of type 2 diabetes: a systematic review and meta-analysis.用于治疗2型糖尿病的多巴胺2激动剂:一项系统评价和荟萃分析。
J Diabetes Metab Disord. 2023 May 12;22(2):931-943. doi: 10.1007/s40200-023-01230-4. eCollection 2023 Dec.
6
Statins and risk of type 2 diabetes: mechanism and clinical implications.他汀类药物与 2 型糖尿病风险:机制与临床意义。
Front Endocrinol (Lausanne). 2023 Sep 19;14:1239335. doi: 10.3389/fendo.2023.1239335. eCollection 2023.
7
Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients.二甲双胍、磺酰脲类和噻唑烷二酮类药物治疗 2 型糖尿病病例报告综述。
Med Sci (Basel). 2023 Aug 15;11(3):50. doi: 10.3390/medsci11030050.
8
Effects of probiotic administration on overweight or obese children: a meta-analysis and systematic review.益生菌干预超重或肥胖儿童的效果:荟萃分析和系统评价。
J Transl Med. 2023 Aug 4;21(1):525. doi: 10.1186/s12967-023-04319-9.
9
Tirzepatide: A Novel Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide 1 Receptor Agonist for the Treatment of Type 2 Diabetes: The First Twincretin.替尔泊肽:一种用于治疗2型糖尿病的新型葡萄糖依赖性促胰岛素多肽/胰高血糖素样肽-1受体激动剂:首个双肠促胰岛素。
Clin Diabetes. 2023 Summer;41(3):367-377. doi: 10.2337/cd22-0060. Epub 2023 Mar 2.
10
Advances in Immunotherapeutic Approaches to Type 1 Diabetes.免疫治疗 1 型糖尿病的新进展。
Int J Mol Sci. 2023 May 25;24(11):9220. doi: 10.3390/ijms24119220.